Literature DB >> 11698035

Metabotropic glutamate mGlu1 receptor mRNA expression in dorsal root ganglia of rats after peripheral nerve injury.

H A Hofmann1, A Siegling, D Denzer, P Spreyer, J De Vry.   

Abstract

Although cerebral and spinal metabotropic glutamate mGlu(1) receptors are thought to be involved in nociception and in the development/maintenance of chronic pain, it is still unclear to what extent mGlu(1) receptors are present in the dorsal root ganglia of peripheral sensory afferents, and whether their expression is affected during development of chronic pain. It was found in the present study that mGlu(1) receptor messenger RNA (mRNA) is present in rat L5 dorsal root ganglia and that it is strongly downregulated after unilateral axotomy of the tibial branch of the sciatic nerve, a model of chronic neuropathic pain. However, as sham-operated animals showed a similar downregulation, it is suggested that peripheral tissue damage is sufficient to result in a reduction of peripheral mGlu(1) receptor expression.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11698035     DOI: 10.1016/s0014-2999(01)01314-0

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  2 in total

1.  The antinociceptive and anxiolytic-like effects of the metabotropic glutamate receptor 5 (mGluR5) antagonists, MPEP and MTEP, and the mGluR1 antagonist, LY456236, in rodents: a comparison of efficacy and side-effect profiles.

Authors:  Geoffrey B Varty; Mariagrazia Grilli; Angelo Forlani; Silva Fredduzzi; Michael E Grzelak; Donald H Guthrie; Robert A Hodgson; Sherry X Lu; Elisa Nicolussi; Annamarie J Pond; Eric M Parker; John C Hunter; Guy A Higgins; Angelo Reggiani; Rosalia Bertorelli
Journal:  Psychopharmacology (Berl)       Date:  2005-01-29       Impact factor: 4.530

2.  Differential regulation of glutamate receptors in trigeminal ganglia following masseter inflammation.

Authors:  Jongseok Lee; Jin Y Ro
Journal:  Neurosci Lett       Date:  2007-05-25       Impact factor: 3.046

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.